Compare AKR Corporindo Tbk (AKRA) vs Dharma Polimetal Tbk. (DRMA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AKR Corporindo Tbk vs Dharma Polimetal Tbk. — how do they compare? AKR Corporindo Tbk trades at Rp1,320 (market cap 26T, 15.27M 24h volume), while Dharma Polimetal Tbk. trades at Rp900 (market cap 4.24T, 1.6M 24h volume). The key difference: AKR Corporindo Tbk is far larger — about 6.1× Dharma Polimetal Tbk.'s market cap, and AKR Corporindo Tbk is more actively traded (15.27M versus 1.6M). Which is the better fit depends on your goals.
| AKRA | DRMA | |
|---|---|---|
Market Cap | 26T | 4.24T |
Volume | 15.27M | 1.6M |
Lot | 152.7K | 16.04K |
Turnover | 20.11B | 1.45B |
Average Price | 1,316.87 | 901.1 |
Value | 20.11B | 1.45B |
Indicative Equilibrium Price | 1,320 | 900 |
Indicative Equilibrium Volume | 4.56K | 200 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AKR Corporindo Tbk
PT AKR Corporindo Tbk was established in Surabaya on November 28, 1977 based on the Notarial Deed No. 46 of Sastra Kosasih, S.H., which was amended by Notarial Deed No. 26 of the same notary dated April 12, 1978 . In 2004, the Company changed its name from PT Aneka Kimia Raya Tbk to PT AKR Corporindo Tbk. PT Aneka Kimia Raya is the largest chemical distributor in Indonesia. The Company is dominantly positioned within the industry, distributing more than 40 chemical products. The Company is foreign investment.
Read more on AKRA →About Dharma Polimetal Tbk.
PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.
Read more on DRMA →
